NEWS DETAILS

Date: 16/04/2025

Pharma exports up by 14 pc to the US in April- Feb. FY25
 
The US market grew 14% despite a large base in April-February 2024-25, according to data shared by the Pharmaceuticals Export Promotion Council of India (Pharmexcil). The US remained the largest destination for India’s pharmaceutical (pharma) exports, accounting for a 36.6% share, or $9.8 billion, during April-February 2024-25. With the US administration expected to impose tariffs on pharma imports, Indian exporters are looking to diversify their markets. India’s pharma exports grew by 6.95% to $26.78 billion between April and February 2024-25. Exports for the full year are expected to be around $27 billion. The US, Europe and Africa are the largest export regions for India, together accounting for almost 70% of the country’s total pharma exports, as per a report.